Amedisys shareholders approve $3.3B UnitedHealth union

Shareholders of healthcare-at-home specialist Amedisys voted in favor of the roughly $3.3 billion pending acquisition by Optum, a subsidiary of UnitedHealth Group, according to a Securities and Exchange Commission filing.

The shareholders approved the adoption of the merger agreement, as well as compensation to the company’s executive officers in connection with the merger.

Still, the deal continues to be under review by the Department of Justice. 

Amedisys filed notifications of the merger with the Federal Trade Commission and Antitrust Division of the Department of Justice in July, and in an SEC filing last month said it received a request for additional information from the DOJ, extending the HSR Act waiting period until the parties have fulfilled the DOJ’s demands. 

Though shareholders have approved the deal, its finalization is subject to approval from certain state regulatory and government authorities. 


In June, UnitedHealth Group announced its plans to purchase the Louisiana-based home healthcare provider in an all-cash deal, beating out Option Care Health. 

According to a May SEC filing, Option Care Health entered into an Agreement and Plan of Merger with the home health company in an all-stock offer, but just one month later entered into a termination agreement that included a termination fee of $106 million payable within 24 hours of the execution of the agreement. 

In February, United Healthcare finalized its acquisition of another home health company, LHC Group, in a $5.4 billion deal, further expanding its reach in the home healthcare market. 



About Author

You may also like


Senior-focused VR company MyndVR will be covered by New York insurer

VR digital therapeutic company MyndVR announced AgeWell New York’s insurance plans for Medicare and Medicaid patients would cover its senior-focused

GoodRx shared health data with Google and Facebook, FTC says

The Federal Trade Commission on Wednesday alleged drug-cost and telehealth platform GoodRx shared consumers’ personal health information with third parties